Cargando…

Multiplexed Single-Cell Measurements of FDG Uptake and Lactate Release Using Droplet Microfluidics

INTRODUCTION: Glucose utilization and lactate release are 2 important indicators of cancer metabolism. Most tumors consume glucose and release lactate at a higher rate than normal tissues due to enhanced aerobic glycolysis. However, these 2 indicators of metabolism have not previously been studied o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sengupta, Debanti, Mongersun, Amy, Kim, Tae Jin, Mongersun, Kellen, von Eyben, Rie, Abbyad, Paul, Pratx, Guillem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444762/
https://www.ncbi.nlm.nih.gov/pubmed/30929606
http://dx.doi.org/10.1177/1533033819841066
Descripción
Sumario:INTRODUCTION: Glucose utilization and lactate release are 2 important indicators of cancer metabolism. Most tumors consume glucose and release lactate at a higher rate than normal tissues due to enhanced aerobic glycolysis. However, these 2 indicators of metabolism have not previously been studied on a single-cell level, in the same cell. OBJECTIVE: To develop and characterize a novel droplet microfluidic device for multiplexed measurements of glucose uptake (via its analog (18)F-fluorodeoxyglucose) and lactate release, in single live cells encapsulated in an array of water-in-oil droplets. RESULTS: Surprisingly, (18)F-fluorodeoxyglucose uptake and lactate release were only marginally correlated at the single-cell level, even when assayed in a standard cell line (MDA-MB-231). While (18)F-fluorodeoxyglucose-avid cells released substantial amounts of lactate, the reverse was not true, and many cells released high amounts of lactate without taking up (18)F-fluorodeoxyglucose. DISCUSSION: These results confirm that cancer cells rely on multiple metabolic pathways in addition to aerobic glycolysis and that the use of these pathways is highly heterogeneous, even under controlled culture conditions. Clinically, the large cell-to-cell variability suggests that positron emission tomography measurements of (18)F-fluorodeoxyglucose uptake represent metabolic flux only in an aggregate sense, not for individual cancer cells within the tumor.